Abstract: The invention relates to a tubular photobioreactor that has a core structure in the shape of a truncated cone and one or more transparent or translucent tubes which are helically wound around the outer surface and/or inner surface of the core structure. Said tubular photobioreactor is characterized in that the transparent or translucent tube has at least two chambers, through at least one of which the cultivation medium flows and through at least one of which a heat transfer medium flows.
Type:
Application
Filed:
October 19, 2010
Publication date:
August 9, 2012
Applicant:
WACKER CHEMIE AG
Inventors:
Christoph Mueller-Rees, Rupert Pfaller, Christian Walter, Fritz Cotta
Abstract: The invention relates to a genetic cluster of strains of Streptococcus thermophilus, which have a lysotype distinct from that of the strains currently used. Within this cluster novel acidifying and texturizing strains have been identified.
Type:
Grant
Filed:
October 2, 2007
Date of Patent:
August 7, 2012
Assignee:
Danisco A/S
Inventors:
Christophe Fremaux, Pascal Fourcassie, Elise Manoury, Philippe Horvath
Abstract: Disclosed herein are an aldolase gene promoter and the use thereof, more particularly, disclosed are a promoter of aldolase gene derived from Lactobacillus casei, having a base sequence of SEQ ID NO: 1, an expression vector containing said promoter, and a recombinant microorganism transformed with said expression vector. The recombinant microorganism transformed with the expression vector containing the disclosed promoter can effectively express a target protein on the surface thereof, and thus will be useful as vaccine vehicles and the like.
Type:
Grant
Filed:
March 21, 2008
Date of Patent:
August 7, 2012
Assignees:
Bioleaders Corporation, Korea Research Institute of Bioscience and Biotechnology
Inventors:
Moon Hee Sung, Chul Joong Kim, Seung-Pyo Hong, Haryoung Poo, Il Han Lee, Ji Yeon Kim, Kwang Kim
Abstract: The bacterium that can perform complete dechlorination of trichloroethene, and the bacteria consortium containing the bacterium are provided, and the method to dechlorinate soils or ground water contaminated with trichloroethene using the bacterium is also provide.
Type:
Application
Filed:
September 23, 2011
Publication date:
August 2, 2012
Applicants:
National University Corporation Tokyo University of University of Agriculture and Technology, PAGE SCIENCE CO., LTD.
Abstract: This invention is a process for the preparation of talc based formulation for LDPE-degrading bacterial consortia. The process comprises preparing an active consortium. The active consortium is divided into four parts in centrifuge tubes. The tubes are spun at 5000 rpm. A supernatant is decanted from the tubes. The tubes are vortexed. Talc is added to each tube. The tubes with talc are again vortexed for some time to produce a homogeneous mixture. The mixture is poured into glass dishes. The dishes are kept at room temperature as aseptically for drying.
Type:
Application
Filed:
October 28, 2011
Publication date:
August 2, 2012
Applicants:
G.B. Patent University of Agriculture and Technology, Department of Biotechnology Delhi
Abstract: The present application relates to cyclic depsipeptides, or derivatives thereof, having the structure of formula (I), and uses thereof, e.g. as inhibitors of kallikrein 7 and human neutrophil elastase.
Type:
Application
Filed:
February 14, 2012
Publication date:
August 2, 2012
Applicant:
NOVARTIS AG
Inventors:
Philipp KRASTEL, Brigitta-Maria LIECHTY, Josef Gottfried MEINGASSNER, Esther SCHMITT, Erwin Paul SCHREINER
Abstract: The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding modules comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example.
Type:
Application
Filed:
May 11, 2010
Publication date:
August 2, 2012
Applicant:
NESTEC S.A.
Inventors:
Annick Mercenier, Sophie Nutten, Guenolee Prioult
Abstract: This disclosure provides herbicide resistant algae and cyanobacteria. This disclosure also provides a method to cultivate algae and cyanobacteria in axenic cultures without contaminating species. Moreover, this disclosure provides transgenic algal and cyanobacterial cells that are capable of high production in high light intensities as typically applied in cultivation. Furthermore, a novel transformation method is provided for algal cells.
Abstract: The current invention relates to the use of a bacterial species in the preparation of a composition adapted for oral administration for the delivery of an agent to a site in the body. The site in the body may be an organ or a tumour site. The bacterial species is a food grade, non-pathogenic, gram-positive bacteria capable of anaerobic growth.
Type:
Application
Filed:
July 16, 2010
Publication date:
July 26, 2012
Applicant:
UNIVERSITY COLLEGE CORK-NATIONAL UNIVERSITY OF IRELAND, CORK
Inventors:
Gerald O'Sullivan, Mark Tangney, Douwe Van Sinderen, Michelle Cronin
Abstract: Methods of enhanced protein transduction are provided. Aspects of the methods include contacting a cell with a transduction protein, where the transduction protein includes both a protein-of-interest domain and a protein transduction domain, and a nucleic acid transfection agent. Also provided are systems and kits that find use in practicing methods according to embodiments of the invention. The methods, systems and kits find use in a variety of different applications.
Abstract: Disclosed herein are compositions for the treatment of a disease in an animal including yeast extract of Saccharomyces cerevisiae, Bacillus licheniformis or Bacillus subtilis spores, and a carrier. Also included are animal feed compositions including the composition for the prevention, control and/or treatment of a disease in an animal and an animal's food/feed. The compositions are useful to prevent, control, and treat diseases such as necrotic enteritis in poultry when used in combination with an anticoccidal ionophore or coccidiosis vaccine.
Abstract: A process for preparing a 2-hydroxy-4-substituted pyridine compound using a microbiological method, a novel microorganism, and a novel compound are provided.
Abstract: Many probiotic Bifidobacteriacea contains an active tetW that renders the cells resistant to tetracycline. This presents a theoretical risk of a horizontal transfer of functional antibiotic genes. The present invention relates to novel tetracycline-sensitive strains of the well-known probiotic Bifidobacterium animalis subsp. lactis strain BB-12® and the use of such novel strains for the preparation of a food or feed product or a dosage form comprising viable organisms.
Abstract: The invention relates to strains of bacteria of the genus Ochrobactrum, that can degrade polylactic acid. The invention also relates to an enzyme that can degrade polylactic acid, characterized in that it is produced by said bacteria strains according to the invention. The invention also relates to the applications of said bacteria strains and said enzyme that can degrade polylactic acid.
Abstract: The invention relates to Gram-negative bacteria carrying an inactivated gene encoding a glycosyltransferase involved in the synthesis of the core of the LPS of said Gram-negative bacteria, wherein said inactivated gene results in the synthesis of a LPS having a modified core. These strains have an attenuated virulence but induce a humoral immunity sufficient for ensuring vaccination of the host.
Abstract: Described herein is a strain of Gordonia sihwensis. The Gordonia sihwensis strain described herein may be used to sequester and/or biodegrade hydrocarbons. In particular, the Gordonia sihwensis strain described herein may be used in the remediation of drill cuttings coated with drilling fluid.
Abstract: The use of Bupleurum kaoi ERF gene in controlling diseases caused by pathogen is provided. The gene with pathogen-resistance is inserted into an appropriate vector, and transformed into plants to enhance the pathogen-resistance so as to attain the purpose of controlling the related diseases. This invention can be applied to the agricultural industry, the pharmaceutical industry, and the food industry.
Abstract: The present invention describes an L-glutamic acid-producing bacterium which belongs to the genus Pantoea, Enterobacter, Klebsiella or Erwinia, wherein the bacterium has been modified by gene recombination to inactivate the rpoS gene. A method is also described for culturing the bacterium in a medium to cause accumulation of L-glutamic acid in the medium, and collecting L-glutamic acid from the medium.
Abstract: To provide a microorganism capable of producing a large amount of carotenoids, mainly astaxanthin, and to provide a method of producing carotenoids using the microorganism, a microorganism having improved carotenoid productivity is used, which is obtainable by breeding a carotenoid producing Paracoccus bacteria which is featured by producing 720 mg or more carotenoid per 1 L of culture medium. Also used is a method of producing carotenoids using the bacterium.
Abstract: A novel class of bacteria is described which has improved efficiency in the production of thanol by anaerobic fermentation of substrates containing carbon monoxide.
Type:
Grant
Filed:
November 13, 2008
Date of Patent:
July 17, 2012
Assignee:
LanzaTech New Zealand Limited
Inventors:
Sean Dennis Simpson, Richard Llewellyn Sydney Forster, Phuong Loan Tran, Matthew James Rowe, Ian Linstrand Warner
Abstract: The present invention relates in general to the field of Bifidobacteria. In particular the present invention relates to the field of Bifidobacteria with an improved resistance to oxidative stress. The inventors have identified a Bifido bacterium that exhibits for example an improved H2O2—resistance.
Type:
Application
Filed:
July 5, 2010
Publication date:
July 12, 2012
Applicant:
NESTEC S.A.
Inventors:
Valeria Mozzetti, Christophe LaCroix, Franck Grattepanche, Fabrizio Carlo Arigoni, Enea Rezzonico, Bernard Berger
Abstract: This invention relates to new Rhodococcus wratislaviensis CNCM I-4088 bacteria or Rhodococcus aetherivorans CNCM I-4089 bacteria that can degrade multiple petroleum compounds in solution in aqueous effluents. The invention also relates to a process for treating aqueous effluents comprising a complex mixture of substances containing native hydrocarbons of gasolines and additives that are present in gasolines or diesel fuel, in which process said bacteria are grown under aerobic conditions in the presence of a growth substrate containing said mixture as a carbon source, and said mixture is at least partially degraded by the bacteria down to the final degradation products—carbon dioxide, water and biomass.
Type:
Application
Filed:
March 26, 2010
Publication date:
July 12, 2012
Applicant:
IFP Energies Nouvelles
Inventors:
Marc Auffret, Francoise Fayolle-Guichard, Gerald Thouand, Charles W. Greer, Diane Labbe
Abstract: Expression systems are disclosed for the direct expression of peptide products into the culture media where genetically engineered host cells are grown. High yield was achieved with a special selection of hosts, and/or fermentation processes which include careful control of cell growth rate, and use of an inducer during growth phase. Special universal cloning vectors are provided for the preparation of expression vectors which include control regions having multiple promoters linked operably with coding regions encoding a signal peptide upstream from a coding region encoding the peptide of interest. Multiple transcription cassettes are also used to increase yield. The production of amidated peptides using the expression systems is also disclosed.
Type:
Grant
Filed:
October 30, 2007
Date of Patent:
July 10, 2012
Assignee:
Unigene Laboratories, Inc.
Inventors:
Nozer M. Mehta, Angelo P. Consalvo, Martha V. L. Ray, Christopher P. Meenan
Abstract: A new supply source of enzymes useful for modification of phospholipids for example, and a method for producing 2-acyl lysophospholipid, a method for producing monoacylglycerol, and a method for producing ceramide, as well as a new method for degumming fat and oil. A novel microorganism is provided, which belongs to Moritella species and is capable of producing enzymes provided with: phospholipase A1 activity; phospholipase C activity; lysophospholipase C activity; and sphingomyelinase activity. By use of those enzymes, the following processes may be effected: hydrolysis of phospholipids for production of 2-acyl lysophospholipid and diacylglycerol; hydrolysis of sphingomyeline for production of ceramide; and degumming of fat and oil.
Type:
Application
Filed:
January 9, 2012
Publication date:
July 5, 2012
Applicant:
TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY
Abstract: The invention provides systems and methods for the delivery of carbon to photoautotrophs. The invention utilizes low energy regeneration of adsorbent for CO2 capture and provides for effective CO2 loading into liquids useful for photoautotroph growth and/or production of photosynthetic products, such as biofuels, via photoautotrophic culture media. The inventive system comprises a fluid/membrane/fluid contactor that provides selective transfer of molecular CO2 via a dense (non-porous) membrane from a carbonate-based CO2 snipping solution to a culture medium where the CO2 is consumed by a photoautotroph for the production of biofuels, biofuel precursors or other commercial products.
Type:
Application
Filed:
March 9, 2012
Publication date:
July 5, 2012
Applicant:
Algenol Biofuels Inc.
Inventors:
Ronald CHANCE, William J. KOROS, Benjamin MCCOOL, James NOEL
Abstract: The invention generally provides a cell culture vessel having at least one first zone and at least one second zone, wherein the first zone is a transfer zone for a culture medium which essentially contains no cells and the second zone is a cell culture zone. The invention further includes methods utilizing the cell culture vessel.
Abstract: A method for dissociating avidin or streptavidin efficiently from a biotin derivative, thereby making it possible to isolate a target material efficiently under a mild condition in a short period, and a dissociation agent for use thereof, are provided. The method for dissociating avidin or streptavidin from a biotin derivative, includes mixing a combination of avidin or streptavidin with desthiobiotin with a water-soluble polymer to which biotin or a derivative thereof is bound.
Abstract: An anti-obesity agent or a glucose tolerance-ameliorating agent containing a bacterium belonging to the genus Bifidobacterium as an active ingredient, wherein the bacterium belonging to the genus Bifidobacterium exhibits a conversion rate from linoleic acid into conjugated linoleic acid of not more than 10%. The present invention is able to provide an anti-obesity agent and a glucose tolerance-ameliorating agent that are effective for the prevention or treatment of obesity or the amelioration of glucose tolerance and also exhibit superior safety, as well as providing foods or beverages containing these agents. Further, the present invention is also able to provide a bacterium of the genus Bifidobacterium, and in particular a Bifidobacterium breve, that is effective for the prevention or treatment of obesity or the amelioration of glucose tolerance and also exhibits superior safety, as well as providing a pharmaceutical composition containing this bacterium.
Abstract: A new thermotolerant Actinomadura sp., which is capable of degrading polyesters, is provided. Compositions comprising the species for use in degrading polyesters are also provided. The invention also relates to methods for degrading polyesters by using the strain and the composition.
Type:
Application
Filed:
August 18, 2010
Publication date:
July 5, 2012
Inventors:
Kim-Chi HOANG, Shu-Feng Yang, Min Tseng, Gwo-Fang Yuan
Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
Abstract: The present invention provides a microorganism belonging to the genus Escherichia in which the activities of glutamine-synthetase adenylyltransferase (GlnE protein) and PII regulatory protein for glutamine synthetase are reduced or lost and which has the ability to form and accumulate L-glutamine or a substance biosynthesized utilizing nitrogen supplied by L-glutamine, and a process for producing L-glutamine or the substance biosynthesized utilizing nitrogen supplied by L-glutamine using the microorganism.
Abstract: The present invention relates to fusion proteins comprising protein light switches and methods of photomanipulating the activity of the proteins. The invention further relates to polynucleotides and vectors encoding the fusion proteins, cells comprising the fusion proteins, and methods of using the fusion proteins to study protein function and analyze subcellular activity, as well as diagnostic and therapeutic methods.
Abstract: The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products fermented with the starter culture.
Type:
Application
Filed:
September 1, 2010
Publication date:
June 28, 2012
Inventors:
Thomas Janzen, Ditte Ellegaard Christiansen
Abstract: Method for production of indolocarbazoles by using rebeccamycin biosynthetic genes. The invention is based on utilization of rebeccamycin biosynthetic genes from Saccharothrix aerocolonigenes for production of indolocarbazoles in related microorganisms (Streptomyces spp.). Method includes the isolation of a DNA fragment from Saccharothrix aerocolonigenes ATCC39243 containing the rebeccamycin biosynthesis gene cluster and the expression of these genes in Streptomyces albus, achieving production of rebeccamycin and derivatives. The invention is suitable for use in the pharmaceutical field.
Type:
Grant
Filed:
October 17, 2002
Date of Patent:
June 26, 2012
Assignee:
Universidad De Oviedo
Inventors:
César Sánchez Reillo, Alfredo Fernandez Braña, José Antonio Salas Fernandez, Carmen Mendez Fernandez
Abstract: The present invention relates to a new microorganism Weissella cibaria BLS13, and more specifically, to a Kimchi-derived new microorganism Weissella cibaria BLS13 which activates an inhibitory effect on avian influenza viruses, and to uses thereof. According to the present invention, the Weissella cibaria BLS13 or a culture medium thereof contains a substance having an anti-viral function, and thus can be used advantageously in feed additives, fermentation products, foods and medicine.
Type:
Application
Filed:
June 17, 2010
Publication date:
June 21, 2012
Applicants:
BIOLEADERS CORPORATION, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, THE INDUSTRY AND ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, KOOKMIN UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHUNGBUK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION
Abstract: A method for the biological decomposition of organic compounds of the group of hydrocarbons, fats, oils, waxes, and derivatives thereof as well as mixtures thereof in media polluted therewith, in the presence of at least one dispersant, wherein the medium polluted with the pollutants is treated with at least one dispersant and with microorganisms.
Type:
Application
Filed:
June 15, 2010
Publication date:
June 21, 2012
Applicants:
TOTAL RAFFINAGE & MARKETING, GEORG FRITZMEIER GMBH & CO. KG
Inventors:
Ursula Fritzmeier, Robert Mallee, Achim Wiessler
Abstract: The present invention provides a method for producing lactic acid bacteria having enhanced immunostimulating activities. Cultivation at a temperature that is higher than the recommended cultivation temperature of the lactic acid bacteria to be used increases the cell wall amount and the cell wall thickness. The immunoregulating activities of the lactic acid bacteria improve in correlation with such increase. The method of the present invention enhances the immunoregulating functions of lactic acid bacteria without requiring any special medium or any special process. This enhancement allows lactic acid bacteria exhibiting excellent immunoregulating activities in a human, or products including such bacteria, such as foods or drinks, medicines or cosmetics to be provided.
Abstract: L-Lysine is produced by culturing in a medium a Vibrio bacterium which has an ability to produce L-lysine, and has been modified so that an activity of a protein encoded by the fucO gene is reduced to produce and accumulate L-lysine in the medium or cells of the bacterium, and collecting L-lysine from the medium or cells.
Abstract: Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel gram negative bacterial mutants useful in vaccines.
Type:
Application
Filed:
June 16, 2011
Publication date:
June 14, 2012
Applicant:
PHARMACIA & UPJOHN COMPANY LLC
Inventors:
David E. Lowery, Troy E. Fuller, Michael J. Kennedy
Abstract: A D-aminoacylase having a high substrate specificity is provided. This D-aminoacylase can produce D-amino acids from N-acetyl-D,L-amino acids conveniently and efficiently at a low cost. A D-aminoacylase produced by a microorganism of genus Defluvibacter; which acts on a N-acetyl-D-amino acid; which has a molecular weight (as determined by electrophoresis) of about 55,000 daltons, and an isoelectric point (as determined by two-dimensional electrophoresis for denatured system) of 5.3; which acts on N-acetyl-D-valine, N-acetyl-D-leucine, and the like, but not on N-acetyl-L-valine, N-acetyl-L-leucine, and the like; which has an optimal temperature of 37° C. (pH 8) and an optimal pH value of 8 to 8.5 at 37° C.; and whose activity is inhibited by Mn2+, Co2+, Ni2+, and Zn2+ each at 1 mmol/L, and by dithiothreitol, 2-mercaptoethanol, o-phenanthroline, and L-cysteine each at 5 mmol/L.
Type:
Application
Filed:
January 6, 2012
Publication date:
June 14, 2012
Applicants:
ISOBE Kimiyasu, DAIICHI PURE CHEMICALS CO., LTD.
Abstract: The present invention relates to compositions, uses thereof, and methods of vaccinating cattle, particularly cows and heifers, against Leptospira borgpetersenii serovar hardjo (type hardjo-bovis) by using Leptospira interrogans serovar hardjo (type hardjoprajitno).
Abstract: The invention relates to compositions and methods for the in vivo production of polypeptides comprising one or more unnatural amino acids. Specifically, the invention provides plasmid systems for the efficient eubacterial expression of polypeptides comprising one or more unnatural amino acids at genetically-programmed positions.
Abstract: The invention relates to mutant strains of the genus Sphingomonas which have a mutation in at least one gene encoding a protein involved in polyhydroxybutyrate (“PHB”) synthesis that allows the mutant strains to produce PHB-deficient sphingans. The invention is also directed to a process for preparing a clarified sphingan solution comprising heating aqueous sphingan solution, in particular PHB-deficient sphingan solution, to a clarification temperature of about 30° C. to about 70° C., and treating the solution with a clarification agent and enzymes. In addition, the invention is directed to a food or industrial product comprising a PHB-deficient and/or clarified sphingan. One particular embodiment of the invention is directed to a clarified, PHB-deficient high-acyl gellan and the processes of making thereof.
Type:
Grant
Filed:
December 2, 2005
Date of Patent:
June 12, 2012
Assignee:
CP Kelco U.S., Inc.
Inventors:
Stan Bower, Ellen Burke, Nancy E. Harding, Yamini N. Patel, J. Carrie Schneider, Dagmar Meissner, Neil A. Morrison, Ralph Bezanson
Abstract: The present invention relates to a novel Paenibacillus polymyxa strain, OSY-DF, and its bioactive mutants. Also provided is a method for using a novel antimicrobial peptide, paenibacillin, isolated from the bacterial strain OSY-DF, and its bioactive variants or fragments. The invention also relates to antimicrobial compositions containing same and methods of their use.
Abstract: The present invention relates to strains of Helicobacter pylori useful for the delivery of biologically active agents. In particular, the present invention provides an isolated strain of H. pylori having: (a) low pathogenicity; (b) ability to naturally transform; and (c) ability to colonise mouse stomach mucosa without host adaptation.
Type:
Application
Filed:
June 3, 2010
Publication date:
June 7, 2012
Inventors:
Mohammed Benghezal, Alma Fulurija, Wei Lu, Hans-Olof Nilsson, Barry Marshall
Abstract: The present invention generally relates to the field of bacteria. In particular, the present invention concerns “short time high temperature” treated probiotics and/or dairy starter cultures and applications of these bacteria. One embodiment of the present invention relates to “short-time high temperature” treated probiotics and/or dairy starter cultures and their use to prepare compositions to treat or prevent inflammatory disorders.
Abstract: Minicells are used to deliver biologically active compounds including radioisotopes, polypeptides, nucleic acids, small molecules, drug molecules, and chemotherapeutic agents. In some cases, the minicell displays ligands or binding moieties that target the minicell to a desired host cell.
Type:
Application
Filed:
November 11, 2011
Publication date:
June 7, 2012
Applicant:
Vaxiion Therapeutics, Inc.
Inventors:
Roger A. Sabbadini, Neil Berkley, Mark W. Surber, Robert Klepper
Abstract: Hydrotesting fluid compositions including stable populations of corrosion reducing microbes, where the populations are is sufficient to reduce or eliminate microbiologically influenced corrosion (MIC).
Abstract: A probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the disclosure may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.
Abstract: Minicells are used to deliver biologically active compounds including radioisotopes, polypeptides, nucleic acids, small molecules, drug molecules, and chemotherapeutic agents. In some cases, the minicell displays ligands or binding moieties that target the minicell to a desired host cell.
Type:
Application
Filed:
November 11, 2011
Publication date:
May 31, 2012
Applicant:
Vaxiion Therapeutics, Inc.
Inventors:
Roger A. Sabbadini, Neil Berkley, Mark W. Surber